Multiple Choice
At concentration greater than 100 µg/mL, the FDPs are capable of:
A) Inhibiting platelet aggregation and release
B) Enhancing platelet aggregation and release
C) Enhancing platelet adhesiveness and release
D) Inhibiting platelet adhesiveness and release
E) None of the above
Correct Answer:
Verified
Correct Answer:
Verified
Q22: The primary physiologic inhibitor of plasmin in-vivo
Q23: Which of the following are laboratory tests
Q24: Which of the following is/are an example(s)
Q25: DIC due to direct activation of factor
Q26: What is meant by primary fibrinolysis?<br>A) Thrombin
Q28: Therapy in DIC is directed at:<br>A) Treatment
Q29: <font face="symbol"></font><sub>2</sub>-Anti-plasmin inhibitor irreversibly binds to the
Q30: Which of the following procedures or disease
Q31: Which laboratory test differentiates primary fibrinolysis from
Q32: Which substance forms a complex with protein